27 related articles for article (PubMed ID: 35228179)
21. Synthesis and evaluation of novel 1, 2, 4-substituted triazoles for urease and anti-proliferative activity.
Ali S; Siddiqui SZ; Abbasi MA; Aziz-Ur-Rehman -; Ali Shah SA; Mohammed Khan K; Saleem RSZ; Manzoor S; Ashraf M; Zia-Ur-Rehman -
Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):209-217. PubMed ID: 35228179
[TBL] [Abstract][Full Text] [Related]
22. Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.
Oubella A; El Mansouri AE; Fawzi M; Bimoussa A; Laamari Y; Auhmani A; Morjani H; Robert A; Riahi A; Youssef Ait Itto M
Bioorg Chem; 2021 Oct; 115():105184. PubMed ID: 34333421
[TBL] [Abstract][Full Text] [Related]
23. An overview of the privileged synthetic heterocycles as urease enzyme inhibitors: Structure-activity relationship.
Sepehri S; Khedmati M
Arch Pharm (Weinheim); 2023 Sep; 356(9):e2300252. PubMed ID: 37401193
[TBL] [Abstract][Full Text] [Related]
24. Two decades of the synthesis of mono- and bis-aminomercapto[1,2,4]triazoles.
Riyadh SM; Gomha SM
RSC Adv; 2020 Jun; 10(42):24994-25012. PubMed ID: 35517465
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
